Limitations
for use
Contraindications
Acute porphyria.
Dicynone 250 ampoules: bronchial asthma, proven hypersensibility
to sulphites.
Precautions
As parenteral administration of Dicynone may induce a
drop in blood pressure it is advised to carefully monitor
patients suffering from blood pressure instability or
hypotension (see Adverse reactions), but no data have
been reported on such a risk during oral administration.
If Dicynone is administered for a reduction of excessive
and/or prolonged menstrual haemorrhages, and no improvement
is observed, possible pathological causes should be looked
for and excluded.
Pregnancy
and lactation
Pregnancy category C: studies in pregnant women or animals
are not available.
As a precaution, Dicynone should not be administered during
the first trimester of pregnancy, whereas during the second
and third trimesters, it should be administered only if
the expected therapeutic benefit is judged as superior
to the potential risk for the foetus.
In the absence of data regarding passage into maternal
milk, lactation during treatment is not advisable or,
if lactation is to continue, the treatment must be stopped. |
|
